Stay updated on GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check60 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study descriptions and criteria for a clinical trial related to pancreatic cancer, while adding new identifiers and collaborators.SummaryDifference22%
- Check68 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding dates of January 28, 2025, and February 3, 2025.SummaryDifference0.6%
- Check111 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.